Acute Chemotherapy-Induced Cardiomyopathy Treated with Intracorporeal Left Ventricular Assist Device in an 8-Year-Old Child

    loading  Checking for direct PDF access through Ovid


Evolution of ventricular assist devices (VADs) leading to miniaturization has made intracorporeal implantation in children feasible. Ventricular assist device therapy for anthracycline-induced cardiomyopathy (CMP) in adults has been reported. We report the case of an 8-year-old child (body surface area 0.97 m2) presenting with anthracycline-induced CMP being successfully treated with an intracorporeal left ventricular assist device (LVAD) as a bridge to candidacy/recovery. We present our institutional algorithm, which advises intracorporeal LVAD implantation for long-term ventricular assist, in children with a body surface area >0.6 m2. Advantages are better mobilization and the possibility to discharge home, leading to enhanced quality of life.

Related Topics

    loading  Loading Related Articles